Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with D9421-C for 8 weeks in
Japanese patients with mild to moderate active Crohn's disease will improve their symptoms of
Crohn's disease and quality of life.